Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-13

Clinical Trial Update: Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications [Phase 4]

View source ↗

Summary

Phase 4 study comparing tolerability of clindamycin 1% with benzoyl peroxide 5% gel versus clindamycin 1.2% with benzoyl peroxide 2.5% topical in acne vulgaris;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin 1% - Benzoyl Peroxide 5% Gel (clindamycin; benzoyl peroxide)
  • Clindamycin 1.2% / Benzoyl Peroxide 2.5% Topical (clindamycin / benzoyl peroxide)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2012-02-13